William R. (Bill) Strohl
Dr. William (Bill) Strohl owns and runs BiStro Biotech Consulting LLC, a consulting company specializing in biologics discovery and early development, especially antibody therapeutics. Bill has over 35 years of experience in biopharmaceutical research, starting with a 17-year academic career in academia at The Ohio State University which he focused on the biosynthesis and molecular biology of doxorubicin biosynthesis and the use of natural product biosynthesis genes to make novel natural products. After that he spent 11 years at Merck Research Labs and 8 years at Janssen R&D. At the end of his career, Bill was VP and Head, Janssen Biotherapeutics, leading all of biologics discovery and early development.